Table 3.
Author | Comments |
---|---|
Kessel et al.38 | In 203 patients with CSU (without control test) 15% showed ATAbs, 34% had IgE antibodies. |
Wan y Wu32 | 60 patients with CSU and 40 healthy controls. ATAbs were present in 27.3% of patients with CSU, (16.6% TGAbs, and 8.3% TPOAbs). |
Lunge, et al.31 | 50 patients with CU, positive AMA were reported in 10%. The autologous serum test was reported positive in 24%, of which 33% presented elevated AMA. |
Aamir et al.33 | 90 patients with CU, ATAbs positive in 42.5% (TGAbs [42.5%] and AMA [57.4%]). |
Amin et al.34 | 221 patients with CU, ATAbs were found in 28% of the patients, more common in women 25.5% vs 11% in males. |
Kim et al.35 | 184 patients with CSU, 10.9 had ATAbs (TPOAbs 25 [13.6%] and TGAbs [20.7%]) |
Ulambayar et al.37 | 125 patients with CSU (64 ASST +, 61 ASST -), AAbs IgG FcεRIα were reported in 24.8% and ATAbs in 24% of patients with CSU, compared to 3.1% in healthy subjects. |
Czarnecka-Operacz, et al.44 | 148 with CSU and 148 healthy controls (33 patients with AT13) Significant difference in ATAbs between the groups. TPOAbs (OR 6.69) (p = 0.0045) TGAbs (OR 6.01) (p = 0.013). |
Halilovic et al.36 | 70 patients with CU and 70 controls. It was reported that 11.43% of patients with abnormal thyroid function had presence of TGAbs 23% and TPOAbs 30% compared with healthy subjects 1.42% and 2.86% respectively. |
CSU: Chronic spontaneous urticaria. ATAbs: Antithyroid antibodies. IgE: Immunoglobulin E. TGAbs: Anti-thyroglobulin antibodies. TPOAbs: Anti-thyroperoxidase antibodies. CU: Chronic urticaria. AMA: Antimicrosomal antibodies. ASST: Autologous serum skin test. AAbs: Autoantibodies. FcεRI: High-affinity IgE receptor.